{
  "trial_id": "NCT01894568",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), duration of Type 2 Diabetes Mellitus (T2DM), baseline Hemoglobin A1c (HbA1c), baseline fasting blood glucose, use of oral antihyperglycemic medications (OAMs), history of severe hypoglycemia, history of diabetic ketoacidosis, renal function (serum creatinine), liver function (liver enzyme measurements), history of cardiovascular disease, history of cancer, baseline triglycerides, sleep/wake cycle regularity.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Baseline Hemoglobin A1c (HbA1c)",
          "baseline Hemoglobin A1c (HbA1c)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Fasting Serum Glucose (FSG)"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of Type 2 Diabetes Mellitus (T2DM)",
        "baseline fasting blood glucose",
        "use of oral antihyperglycemic medications (OAMs)",
        "history of severe hypoglycemia",
        "history of diabetic ketoacidosis",
        "renal function (serum creatinine)",
        "liver function (liver enzyme measurements)",
        "history of cardiovascular disease",
        "history of cancer",
        "baseline triglycerides",
        "sleep/wake cycle regularity"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Total Cholesterol, Triglycerides, Serum Creatinine,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Baseline Hemoglobin A1c (HbA1c)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)",
        "Fasting Serum Glucose (FSG)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Duration of Diabetes",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose",
        "Total Cholesterol",
        "Triglycerides",
        "Serum Creatinine"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Duration of Diabetes, HbA1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Baseline Hemoglobin A1c (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)",
        "Fasting Serum Glucose (FSG)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Duration of Diabetes",
        "Fasting Plasma Glucose",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, hemoglobin A1c (HbA1c) at screening, fasting plasma glucose at screening, systolic blood pressure, diastolic blood pressure, heart rate, smoking status, history of cardiovascular disease, history of hypertension, history of dyslipidemia, use of oral antihyperglycemic medications, use of lipid-lowering medications, use of antihypertensive medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Baseline Hemoglobin A1c (HbA1c)",
          "hemoglobin A1c (HbA1c) at screening"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Fasting Serum Glucose (FSG)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "duration of type 2 diabetes mellitus",
        "fasting plasma glucose at screening",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "smoking status",
        "history of cardiovascular disease",
        "history of hypertension",
        "history of dyslipidemia",
        "use of oral antihyperglycemic medications",
        "use of lipid-lowering medications",
        "use of antihypertensive medications"
      ]
    }
  }
}